GSK (GSK) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

GSK Revenue Highlights

Latest Revenue (Y)

$30.33B

Latest Revenue (Q)

$7.36B

Main Segment (Y)

Sub Total

Main Geography (Y)

UNITED STATES

GSK Revenue by Period

GSK Revenue by Year

Date	Revenue	Change
2023-12-31	$30.33B	3.42%
2022-12-31	$29.32B	-14.04%
2021-12-31	$34.11B	0.04%
2020-12-31	$34.10B	1.02%
2019-12-31	$33.75B	9.52%
2018-12-31	$30.82B	2.10%
2017-12-31	$30.19B	8.24%
2016-12-31	$27.89B	16.58%
2015-12-31	$23.92B	3.99%
2014-12-31	$23.01B	-13.20%
2013-12-31	$26.50B	0.28%
2012-12-31	$26.43B	-3.49%
2011-12-31	$27.39B	-3.54%
2010-12-31	$28.39B	0.08%
2009-12-31	$28.37B	16.49%
2008-12-31	$24.35B	7.20%
2007-12-31	$22.72B	-2.19%
2006-12-31	$23.23B	7.23%
2005-12-31	$21.66B	8.38%
2004-12-31	$19.99B	-6.79%
2003-12-31	$21.44B	1.08%
2002-12-31	$21.21B	3.30%
2001-12-31	$20.53B	13.58%
2000-12-31	$18.08B	112.94%
1999-12-31	$8.49B	6.35%
1998-12-31	$7.98B	0.04%
1997-12-31	$7.98B	-4.33%
1996-12-31	$8.34B	-20.49%
1995-12-31	$10.49B	85.47%
1994-06-30	$5.66B	14.73%
1993-06-30	$4.93B	-

GSK generated $30.33B in revenue during NA 2023, up 3.42% compared to the previous quarter, and up 98.40% compared to the same period a year ago.

GSK Revenue by Quarter

Date	Revenue	Change
2024-03-31	$7.36B	-8.56%
2023-12-31	$8.05B	-1.17%
2023-09-30	$8.15B	13.50%
2023-06-30	$7.18B	3.27%
2023-03-31	$6.95B	-5.76%
2022-12-31	$7.38B	-5.79%
2022-09-30	$7.83B	12.99%
2022-06-30	$6.93B	-29.15%
2022-03-31	$9.78B	2.66%
2021-12-31	$9.53B	4.96%
2021-09-30	$9.08B	12.17%
2021-06-30	$8.09B	9.09%
2021-03-31	$7.42B	-15.12%
2020-12-31	$8.74B	1.08%
2020-09-30	$8.65B	13.41%
2020-06-30	$7.62B	-16.13%
2020-03-31	$9.09B	2.15%
2019-12-31	$8.90B	-5.18%
2019-09-30	$9.38B	20.18%
2019-06-30	$7.81B	1.93%
2019-03-31	$7.66B	-6.54%
2018-12-31	$8.20B	1.30%
2018-09-30	$8.09B	10.70%
2018-06-30	$7.31B	1.22%
2018-03-31	$7.22B	-5.46%
2017-12-31	$7.64B	-2.60%
2017-09-30	$7.84B	7.14%
2017-06-30	$7.32B	-0.87%
2017-03-31	$7.38B	-2.66%
2016-12-31	$7.59B	0.58%
2016-09-30	$7.54B	15.46%
2016-06-30	$6.53B	4.86%
2016-03-31	$6.23B	-0.91%
2015-12-31	$6.29B	2.60%
2015-09-30	$6.13B	4.06%
2015-06-30	$5.89B	4.73%
2015-03-31	$5.62B	-9.12%
2014-12-31	$6.19B	9.56%
2014-09-30	$5.65B	1.53%
2014-06-30	$5.56B	-0.93%
2014-03-31	$5.61B	-18.72%
2013-12-31	$6.91B	6.08%
2013-09-30	$6.51B	-1.63%
2013-06-30	$6.62B	2.27%
2013-03-31	$6.47B	-4.87%
2012-12-31	$6.80B	4.21%
2012-09-30	$6.53B	1.01%
2012-06-30	$6.46B	-2.68%
2012-03-31	$6.64B	-4.84%
2011-12-31	$6.98B	-1.77%
2011-09-30	$7.10B	5.71%
2011-06-30	$6.72B	2.05%
2011-03-31	$6.58B	-8.50%
2010-12-31	$7.20B	5.64%
2010-09-30	$6.81B	-3.02%
2010-06-30	$7.03B	-4.51%
2010-03-31	$7.36B	-9.11%
2009-12-31	$8.09B	19.77%
2009-09-30	$6.76B	0.16%
2009-06-30	$6.75B	-0.33%
2009-03-31	$6.77B	-2.04%
2008-12-31	$6.91B	17.48%
2008-09-30	$5.88B	0.14%
2008-06-30	$5.87B	3.31%
2008-03-31	$5.69B	-5.18%
2007-12-31	$6.00B	-

GSK generated $7.36B in revenue during Q1 2024, up -8.56% compared to the previous quarter, and up 99.82% compared to the same period a year ago.

GSK Revenue Breakdown

GSK Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 22	Dec 21
Sub Total	$8.96B	-
New And Speciality	-	$9.97B

GSK's latest annual revenue breakdown by segment (product or service), as of Dec 22: Sub Total (100.00%).

GSK Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Rest Of World	$13.81B	$14.09B	$18.05B	$18.56B	$18.92B
UNITED STATES	$15.82B	$14.54B	$15.09B	$14.56B	$13.89B

GSK's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (53.38%), and Rest Of World (46.62%).

GSK Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
JNJ	Johnson & Johnson	$85.15B	$22.47B
MRK	Merck	$60.12B	$16.66B
ABBV	AbbVie	$54.32B	$14.46B
NVS	Novartis	$46.66B	$11.83B
AZN	AstraZeneca	$45.81B	$12.68B
BMY	Bristol-Myers Squibb Company	$45.01B	$11.89B
SNY	Sanofi	$43.07B	$11.12B
GSK	GSK	$30.33B	$7.36B
AMGN	Amgen	$28.19B	$8.50B
GILD	Gilead Sciences	$27.12B	$7.55B
BIIB	Biogen	$9.84B	$2.47B

GSK Revenue FAQ

What is GSK’s yearly revenue?

GSK's yearly revenue for 2023 was $30.33B, representing an increase of 3.42% compared to 2022. The company's yearly revenue for 2022 was $29.32B, representing a decrease of -14.04% compared to 2021. GSK's yearly revenue for 2021 was $34.11B, representing an increase of 0.04% compared to 2020.

What is GSK’s quarterly revenue?

GSK's quarterly revenue for Q1 2024 was $7.36B, a -8.56% decrease from the previous quarter (Q4 2023), and a 5.93% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $8.05B, a -1.17% decrease from the previous quarter (Q3 2023), and a 9.16% increase year-over-year (Q4 2022). GSK's quarterly revenue for Q3 2023 was $8.15B, a 13.50% increase from the previous quarter (Q2 2023), and a 4.06% increase year-over-year (Q3 2022).

What is GSK’s revenue growth rate?

GSK's revenue growth rate for the last 3 years (2021-2023) was -11.10%, and for the last 5 years (2019-2023) was -10.15%.

What are GSK’s revenue streams?

GSK's revenue streams in c 22 are Sub Total

What is GSK’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of GSK was Sub Total. This segment made a revenue of $8.96B, representing 100.00% of the company's total revenue.